Search

Nano and Silicone Technology News

Innovation Award for Consumer Specialties

Essen, 2012-12-18

The Innovation Award honors employees for outstanding innovations in the field of chemistry. Dr. Klaus Engel, Chairman of the Executive Board, and Patrik Wohlhauser, Executive Board member, announced the winners of this year's Innovation Award at an evening event on December 12 during the Christmas Colloquium held in Essen.

ALBIPOX 9001 LTM, a dual-curing textile adhesive for use in fiber-reinforced composite materials, was the winner in the “New Product/New System Solution” category. It was developed in the Consumer Specialties Business Unit by a team comprising Kerstin Schlotter, Dr. Stephan Sprenger, and Ralf Pläger. A major textile manufacturer that supplies the composites industry with fiberglass and carbon fiber materials, particularly in the areas of wind power, shipbuilding and aeronautics, wanted to offer self-adhesive textiles to its customers. The company commissioned Evonik Hanse to develop a suitable pressure-sensitive adhesive. The key to the solution was supplementing the typically used epoxy resins with acrylate groups, which meant using a hybrid technology with a UV cross-linking mechanism. The self-adhesive substances represent an innovation in the composite market and offer major advantages to users.

 The winners of the Evonik Innovation Award 2012 with Dr. Klaus Engel and Patrik Wohlhauser: Kerstin Schlotter, Dr. Stephan Sprenger (3rd from left), Ralf Pläger (4th from left)

The winners of the Evonik Innovation Award 2012 with Dr. Klaus Engel and Patrik Wohlhauser: Kerstin Schlotter, Dr. Stephan Sprenger (3rd from left), Ralf Pl├Ąger (4th from left)

Contact

Dr. Stephan Sprenger

Contact

  • Company Information

    Evonik, the creative industrial group from Germany, is one of the world leaders
    in specialty chemicals. Profitable growth and a sustained increase in the value of the company form the heart of Evonik’s corporate strategy. Its activities focus on the key megatrends health, nutrition, resource efficiency and globalization. Evonik benefits specifically from its innovative prowess and integrated technology platforms.

    Evonik is active in over 100 countries around the world. In fiscal 2012 more than 33,000 employees generated sales of around €13.6 billion and an operating profit (adjusted EBITDA) of about €2.6 billion.

  • Disclaimer

    In so far as forecasts or expectations are expressed in this press release or where our statements concern the future, these forecasts, expectations or statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating environment. Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained in this release.